Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;47(5):1319-24.
doi: 10.1128/JCM.02280-08. Epub 2009 Mar 4.

Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa

Affiliations

Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa

Nicole Wolter et al. J Clin Microbiol. 2009 May.

Abstract

Fluoroquinolones are not indicated for use for the treatment of pneumonia in children; however, non-levofloxacin-susceptible Streptococcus pneumoniae (NLSSP) has emerged in South Africa among children receiving treatment for multidrug-resistant tuberculosis. This study aimed to genotypically characterize NLSSP isolates. Invasive isolates were collected through active national laboratory-based surveillance for invasive pneumococcal disease (IPD) from 2000 through 2006 (n = 19,404). Carriage studies were conducted at two hospitals for patients with tuberculosis in two provinces. Phenotypic characterization was performed by determination of MICs and serotyping. Fluoroquinolone resistance mutations were identified, and clonality was investigated by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Twelve non-levofloxacin-susceptible cases of IPD were identified, and all were in children <15 years of age. Ten isolates were serotype 19F and formed two clusters according to their PFGE profiles, antibiogram types, and fluoroquinolone resistance-conferring mutations. All nine carriage isolates from children in hospital A were NLSSP, serotype 19F, were indistinguishable by PFGE, and were related to invasive isolates in cluster 2. Of 26 child carriers in hospital B, 22 (85%) were colonized with NLSSP. The isolates were indistinguishable by PFGE, although they displayed two serotypes, serotypes 19F and 23F. The isolates were related to invasive isolates in cluster 1; however, higher levofloxacin MICs and different fluoroquinolone resistance mutations were suggestive of horizontal gene transfer. A serotype 23F carriage isolate displayed increased fitness compared with the fitness of an otherwise indistinguishable serotype 19F carriage isolate. These data suggest that a low-level non-levofloxacin-susceptible strain transformed into a highly resistant strain under antibiotic pressure and underwent capsular switching in order to have increased fitness.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
PFGE dendrogram indicating the clonality of the fluoroquinolone-resistant invasive and carriage pneumococcal isolates. An “A” in the isolate number indicates carriage isolates from hospital A; a “B” indicates carriage isolates from hospital B. GA, Gauteng Province; WC, Western Cape Province; KZN, KwaZulu-Natal Province.
FIG. 2.
FIG. 2.
Growth curves at 37°C of a non-levofloxacin-susceptible invasive isolate (isolate 4) and a carriage isolate (isolate A137) from hospital A (PFGE cluster 2) and an invasive isolate (isolate 5) and carriage isolates (isolates B08 and B11) from hospital B (PFGE cluster 1). Serotypes are indicated in parentheses.

Similar articles

Cited by

References

    1. Balsalobre, L., M. J. Ferrandiz, J. Linares, F. Tubau, and A. G. de la Campa. 2003. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 472072-2081. - PMC - PubMed
    1. Calfee, D. P. 2005. Rifamycins, p. 374-388. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA.
    1. Chen, F. J., and H. J. Lo. 2003. Molecular mechanisms of fluoroquinolone resistance. J. Microbiol. Immunol. Infect. 361-9. - PubMed
    1. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Duesberg, C. B., S. Malhotra-Kumar, H. Goossens, L. McGee, K. P. Klugman, T. Welte, and M. W. Pletz. 2008. Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes. Antimicrob. Agents Chemother. 524191-4193. - PMC - PubMed

Publication types

MeSH terms